ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2013

Abstract Number: 987

Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention

Candace H. Feldman1, Gregory A. Culley2, Erika Brown3, Chanele R. Assencoa2, LeRoi S. Hicks4 and Daniel H. Solomon3,5, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital,Harvard Medical School, Boston, MA, 2Family Health Center of Worcester, Inc., Worcester, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Division of Hospital Medicine, UMass Memorial Medical Center, Worcester, MA, 5Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: access to care and health disparities, Intervention

Session Information

Title: ARHP Education/Community Programs

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Early and sustained access to rheumatology care can improve access to disease-modifying medications and reduce disparities in outcomes. In one state, more than one-half of community health center (CHC) medical directors felt that their predominantly low-income, underserved patients required better access to rheumatology care. We pilot tested an intervention that utilized a patient navigator- a layperson trained to provide a range of education, advocacy and care coordination services- to improve access to rheumatology and musculoskeletal care.  

Methods: We partnered with a CHC that cares for over 30,000 patients each year, 95% with income levels below 200% of poverty. The CHC medical director identified an affiliated community health worker to serve as the patient navigator. We developed a rheumatology/musculoskeletal disease curriculum to train the navigator and provided comprehensive patient resources and pamphlets for distribution. We identified established patients with rheumatic and musculoskeletal diseases by ICD-9 code, and primary care providers (PCPs) confirmed whether each patient would benefit from the navigator’s assistance. All patients requiring a new rheumatology appointment were also referred to the navigator. We conducted semi-structured interviews with patients to assess need and tracked all navigator services provided.

Results: Of the 695 patients initially identified by ICD-9 code with possible rheumatic and musculoskeletal diseases, 125 were referred to the navigator; 29 also required new rheumatology appointments. On average, 5 new referrals (range 2-10) were received weekly. After 3 months, 31 (28%) patients were actively working with the navigator, 81 (72%) patients’ PCPs were actively in communication with the navigator, and 62/81 (77%) of these patients were in the process of being engaged (outreach attempts made or waiting for appointments to be scheduled). Two of the 125 (2%) patients declined participation. Among the 31 actively engaged patients, navigator’s services included direct coordination of appointments and repeated reminders prior to the visit (n=26, 84%), facilitation of communication between providers (n=31, 100%), transportation arrangements (n=7, 23%), financial services including provisions for affordable medications (n=4, 13%), coordination of live interpreters (n=2, 6%), and organization of senior services (n=2, 6%). Of the 29 patients scheduled to see rheumatologists, 14/17 (82%) successfully kept their appointments and 12 appointments are upcoming.

Conclusion: This CHC-based rheumatology navigator pilot demonstrates the feasibility and acceptability of subspecialty navigators to improve access to care for underserved patients. Further research is needed to assess the effectiveness and costs of the patient navigator.


Disclosure:

C. H. Feldman,
None;

G. A. Culley,
None;

E. Brown,
None;

C. R. Assencoa,
None;

L. S. Hicks,
None;

D. H. Solomon,

Lilly, Amgen, CORRONA,

2,

Lilly, Novartis, BMS, Pfizer,

6,

Lilly, BMS, Novartis,

9.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-access-to-subspecialty-care-for-underserved-communities-a-rheumatology-patient-navigator-pilot-intervention/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology